Tuberculosis trials in Saudi Arabia
1 of 1 trials · From ClinicalTrials.gov, checked 13 November 2026. Ask the study team whether a trial fits you.
- Phase 2Not yet taking people in Saudi ArabiaAIPH-TB: AI-Optimised Pyrazinamide-Hydroxychloroquine vs Standard RIPE for Drug-Sensitive Pulmonary Tuberculosis - A Phase II RCT
- Where
- Riyadh
- Age
- 18 years to 65 years
- People
- 200
- Run by
- Ministry of Health, Saudi Arabia
See details and how to joinNCT07467252